AC Immune SA (ACIU)
2.97
-0.04
(-1.33%)
USD |
NASDAQ |
May 06, 16:00
2.98
+0.01
(+0.34%)
Pre-Market: 20:00
AC Immune EPS Diluted (Quarterly) : -0.1914 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 8.255 |
| Novartis AG | 1.654 |
| EvoNext Holdings SA | -- |
| Kuros Biosciences Ltd. | -- |
| Basilea Pharmaceutica AG | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.89M |
| Revenue (Quarterly) | 1.428M |
| Total Expenses (Quarterly) | 20.31M |
| Enterprise Value | 214.54M |
| Profit Margin (Quarterly) | -1.32K% |
| Earnings Yield | -27.62% |